Q4 2019 Holdings
Filed 2020-05-18 | 64 holdings | $47.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $10.8K | 28,830 | 0.0% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $14.1K | 390,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $14.3K | 133,300 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $15.9K | 66,000 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $19.1K | 293,284 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $20.4K | 93,422 | 0.0% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $1.7M | 36,500 | 3.6% |
| Ascendis Pharma AS(ASND) | Sponsored ADR | 04351P101 | $1.9M | 13,800 | 4.0% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $2.3M | 14,000 | 4.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $5.0M | 43,300 | 10.4% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $8.8M | 104,284 | 18.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $13.6M | 45,700 | 28.3% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $14.4M | 336,000 | 30.0% |